目的 分析2015-2016年曲靖市第一人民醫(yī)院注射用輔助用藥的使用情況，為醫(yī)院管理和臨床規(guī)范使用提供參考。方法 2015-2016年曲靖市第一人民醫(yī)院注射用輔助用藥的使用數(shù)據(jù)，對(duì)使用金額、藥占比、用藥頻度（DDDs）等進(jìn)行統(tǒng)計(jì)分析。結(jié)果 2015-2016年輔助用藥的使用金額和藥占比具顯著下降。進(jìn)入全院藥品金額排名前20位的輔助用藥品種數(shù)也降低。注射用紅花黃色素的使用金額從2015年的第1位降到2016年的第15位，注射用血栓通則從2015年的第2位降到2016年的15位之外。2015-2016年維生素B₆注射液的DDDs均排名第1位。2015、2016年，上報(bào)的藥品不良反應(yīng)分別為15、6例。2015-2016年主要不合理用藥為無(wú)適應(yīng)癥用藥和用法用量不合理，構(gòu)成比分別為38.81%、30.00%，21.15%、20.50%，2016年較2015年不合理病例數(shù)明顯降低。結(jié)論 加強(qiáng)輔助用藥管理有效降低輔助用藥費(fèi)用和藥占比，規(guī)范輔助用藥使用，促進(jìn)患者的用藥安全。

Objective To investigate the utilization of adjuvant drugs for injection in Qujing First People's Hospital from 2015 to 2016, so as to provide reference for standard management and regular application in clinic. Methods Data of adjuvant drugs for injection in Qujing First People's Hospital from 2015 to 2016 were selected, and consumption sum, constituent ratio, and frequency of drug use (DDDs) were retrospectively analyzed. Results Consumption sum and constituent ratio of adjuvant drugs were significantly decreased from 2015 to 2016. The number of adjuvant drugs with top 20 consumption sum was dropped. Consumption sum of Safflower Yellow for injection ranked the first in 2015, and decreased to the fifth in 2016. Consumption sum of Xueshuantong for injection ranked the second in 2015, and decreased over the fifth in 2016. DDDs of Vitamin B₆ Injection ranked the first from 2015 to 2016. The cases of ADR were 15 and 6 in 2015 and 2016. The main irrational drug use was inappropriate indications and inappropriate usage and dosage, and the constituent ratio were 38.81% and 30.00%, 21.15% and 20.50%. Compared with those in 2015, the cases of irrational drug use were decreased in 2016. Conclusion The management of adjuvant drugs should be strengthened to effectively reduce the cost and proportion of adjuvant drugs, and standardized the application and promote the medication safety of patients.